The Audiologist Informer

HearingTracker Audiologist Matthew Allsop recounts his experience in attending the European Parliament meeting on untreated hearing loss.

Despite significant headwinds from an industry-wide US sales downturn and the macroeconomic uncertainties of January-March 2025, WSA posted satisfactory results and benefited from the successful launches of the Signia BCT IX and Widex Allure.

A study conducted in Brazil on 805 people in their 50s confirmed that those with hearing loss had an increased risk of cognitive decline.

Sales for Sonova—parent company to Phonak and Unitron—reached CHF 3.8B (US$4.6B), an increased of 7.6% in local currencies, driven by the successful launch of the Infinio in August. Sonova has announced that CEO Arnd Kaldowski will leave at the end of September for personal reasons with former WSA CEO Eric Bernard replacing him.

Recent federal budget proposals to eliminate Early Hearing Detection and Intervention (EHDI) may force many states to scale back or discontinue their screening services entirely.

The parent company of Oticon experienced a soft first quarter in response to headwinds from a slowdown in global hearing aid sales (about -5% in US industry sales), as well as strong comparatives from last year at this time (Oticon launched its new Intent hearing aid in February 2024).

Researchers have identified the area in the brain, called the insula, that shows significant changes in people who struggle with speech in noise.

The National Academy of Sciences Engineering and Medicine is hosting a webinar on its upcoming report, which seeks to establish better standardized and meaningful outcome measures for hearing care interventions.